The chief scientific officer and chief medical officer of Ultragenyx Gene Therapy discussed the company’s future research in gene therapies.
Sam Wadsworth, PhD
Advertisement
Chief Scientific Officer, Ultragenyx Pharmaceuticals
Articles by Sam Wadsworth, PhD
Sam Wadsworth, PhD, chief scientific officer of Ultragenyx Pharmaceuticals, discussed the company’s platform for efficiently producing AAV vectors.
Advertisement
Latest Updated Articles
Improving AAV Production With HeLa PlatformPublished: August 6th 2021 | Updated:
- Selecting AAV Manufacturing Platforms
Published: August 20th 2021 | Updated:
